Healthcare Professionals Investor Login Turkish
About Trustlife Labs Drug R&D Center News Contact
Trustlife

Scientific Documents

Exploring N-Ferrocenylmethylaniline Derivatives as Potent Anti-Breast Cancer Agents: Insights from Computational Chemistry, Pharmacokinetics, and QSAR Analysis

Breast CancerInnovative Drug DevelopmentPanel

19.12.2023

Exploring N-Ferrocenylmethylaniline Derivatives as Potent Anti-Breast Cancer Agents: Insights from Computational Chemistry, Pharmacokinetics, and QSAR Analysis

Exploring N-Ferrocenylmethylaniline Derivatives as Potent Anti-Breast Cancer Agents: Insights from Computational Chemistry, Pharmacokinetics, and QSAR Analysis

Nadjiba ZEGHEBa,b *, Aicha ADAIKAa , Touhami LANEZa , Tuba Tüylü Küçükkılınç

Exploring N-Ferrocenylmethylaniline Derivatives as Potent Anti-Breast Cancer Agents: Insights from Computational Chemistry, Pharmacokinetics, and QSAR Analysis from Trustlife

You may also be interested in

  • Visit of Minister of Health Prof. Dr. Kemal Memişoğlu to Trustlife
    Visits

    Visit of Minister of Health Prof. Dr. Kemal Memişoğlu to Trustlife

  • Multi-Target Neuroprotective Compound Exhibits EAAT2-Modulating and Alzheimer’s Pathology–Attenuating Effects in In Vitro and In Vivo Models
    Scientific Documents

    Multi-Target Neuroprotective Compound Exhibits EAAT2-Modulating and Alzheimer’s Pathology–Attenuating Effects in In Vitro and In Vivo Models

  • Clinical Application for the First National Alzheimer’s Drug – Trustlife Press Release – 20.02.2026
    Recent News

    Clinical Application for the First National Alzheimer’s Drug – Trustlife Press Release – 20.02.2026

Trustlife
About Trustlife Labs Drug R&D Center Contact